🟢 Xenetic Biosciences is trading 8.5% up today in pre-market amid stronger overnight equity sentiment

Xenetic Biosciences is trading 8.54% up at $2.67, with the rebound broadly supported by stronger overnight equity sentiment after closing September 17, 2026, at $2.46.

• No new company announcement dated September 18 was identified; the latest major development remains the proposed all-stock Santersus acquisition, announced September 16.
• Nasdaq gained 0.59%, while Asian markets reacted positively to the Bank of Japan decision.
• The move follows a 48.71% decline on September 16 and a 12.33% recovery on September 17.